Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Toronto S.E.
21/08/2026
|
5-day change | 1st Jan Change | ||
| 0.1100 CAD | 0.00% |
|
0.00% | -15.38% |
| Market Cap | 41.54M 30.03M 25.74M 24.08M 22.01M 2.88B 41.98M 285M 111M 1.44B 113M 110M 4.78B | P/E 2026 * |
-3.67x | P/E 2027 * | -2.75x |
|---|---|---|---|---|---|
| Enterprise Value | 41.54M 30.03M 25.74M 24.08M 22.01M 2.88B 41.98M 285M 111M 1.44B 113M 110M 4.78B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 8.31x |
| Free-Float |
86.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 month | -8.33% | ||
| 3 months | -29.03% | ||
| 6 months | -21.43% | ||
| Current year | -15.38% |
| 1 week | 0.1 |  | 0.11 |
| 1 month | 0.1 | | 0.12 |
| Current year | 0.1 | | 0.2 |
| 1 year | 0.1 | | 0.2 |
| 3 years | 0.1 | | 0.91 |
| 5 years | 0.1 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 12/08/2024 |
James Parsons
DFI | Director of Finance/CFO | 60 | 11/10/2024 |
David Burke
IRC | Investor Relations Contact | - | 11/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 19/04/2012 |
Steven Sangha
BRD | Director/Board Member | - | 24/04/2023 |
David Paterson
BRD | Director/Board Member | - | 01/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/7/26 | Sell | Company | -115,000 | 0.0305% | ||
| 22/5/26 | Option | Director | 173,418 | 0.0499% | ||
| 27/2/26 | Option | Director | 377,970 | 0.1123% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -38.89% | -85.90% | 30.17M | |
| -0.25% | -1.20% | -16.16% | +19.84% | 126B | |
| +1.17% | -0.55% | -21.59% | +1.98% | 12.26B | |
| -0.00% | -0.98% | +100.78% | +150.42% | 10.9B | |
| -1.04% | -9.34% | -52.54% | -68.79% | 4.14B | |
| +2.94% | +1.47% | -22.09% | +56.66% | 2.69B | |
| -2.08% | +6.47% | -34.44% | -71.70% | 1.8B | |
| -2.25% | -2.67% | -25.37% | -13.22% | 1.66B | |
| -3.08% | -6.50% | -37.51% | -39.82% | 1.61B | |
| Average | -0.54% | +0.59% | -16.42% | -5.61% | 17.94B | |
| Weighted average by Cap. | -0.18% | -2.48% | -10.23% | +23.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.61M 3.1M 2.9M 2.65M 346M 5.05M 34.29M 13.33M 174M 13.57M 13.28M 575M |
| Net income | -12.83M -9.27M -7.95M -7.43M -6.8M -888M -12.96M -87.98M -34.21M -446M -34.82M -34.07M -1.48B | -19.77M -14.29M -12.25M -11.46M -10.48M -1.37B -19.98M -136M -52.73M -687M -53.67M -52.51M -2.27B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | CA$0.1100 | 0.00% | 121,565 |
| 20/08/26 | CA$0.1100 | 0.00% | 44,374 |
| 19/08/26 | CA$0.1100 | +4.76% | 103,101 |
| 18/08/26 | CA$0.1050 | +5.00% | 49,901 |
| 17/08/26 | CA$0.1000 | -9.09% | 232,603 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1100CAD
Average target price
0.4500CAD
Spread / Average Target
+309.09%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
